Debiopharm and Cenix Partner on Preclinical Services
Debiopharm says Cenix’ RNAi screening technology was the key reason in selecting the CRO for its drug development services.
Debiopharm says Cenix’ RNAi screening technology was the key reason in selecting the CRO for its drug development services.
Fresenius Kabi says drug shortages won’t be affected as it recalls a lot of magnesium sulphate, and there’s news from Glenmark and J&J – welcome to in-Pharmatechnologist.com's recall round-up.
Ethica Clinical Research has chosen Alion for accreditation of its Human Research Protection Program (HRPP).
Vaccine manufacturer Sinovac has updated its GMP accreditation to international standards, short of the deadline set by the CFDA.
Clean air solutions firm Camfil has opened a new £2.4m ($3.6m) facility in the UK offering customers better support and faster delivery times in Europe.